Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures

Hui Ting Chen, Mon Juan Lee, Chung Hwan Chen, Shu Chun Chuang, Li Fu Chang, Mei Ling Ho, Shao Hung Hung, Yin Chih Fu, Yan Hsiung Wang, Hsin I. Wang, Gwo Jaw Wang, Lin Kang, Je Ken Chang

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Aging has less effect on adipose-derived mesenchymal stem cells (ADSCs) than on bone marrow-derived mesenchymal stem cells (BMSCs), but whether the fact holds true in stem cells from elderly patients with osteoporotic fractures is unknown. In this study, ADSCs and BMSCs of the same donor were harvested and divided into two age groups. Group A consisted of 14 young patients (36.4 ± 11.8 years old), and group B consisted of eight elderly patients (71.4 ± 3.6 years old) with osteoporotic fractures. We found that the doubling time of ADSCs from both age groups was maintained below 70 hrs, while that of BMSCs increased significantly with the number of passage. When ADSCs and BMSCs from the same patient were compared, there was a significant increase in the doubling time of BMSCs in each individual from passages 3 to 6. On osteogenic induction, the level of matrix mineralization of ADSCs from group B was comparable to that of ADSCs from group A, whereas BMSCs from group B produced least amount of mineral deposits and had a lower expression level of osteogenic genes. The p21 gene expression and senescence-associated β-galactosidase activity were lower in ADSCs compared to BMSCs, which may be partly responsible for the greater proliferation and differentiation potential of ADSCs. It is concluded that the proliferation and osteogenic differentiation of ADSCs were less affected by age and multiple passage than BMSCs, suggesting that ADSCs may become a potentially effective therapeutic option for cell-based therapy, especially in elderly patients with osteoporosis.

Original languageEnglish
Pages (from-to)582-593
Number of pages12
JournalJournal of Cellular and Molecular Medicine
Volume16
Issue number3
DOIs
Publication statusPublished - 2012 Mar 1

Fingerprint

Osteoporotic Fractures
Mesenchymal Stromal Cells
Bone Marrow
Age Groups
Galactosidases

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Cell Biology

Cite this

Chen, Hui Ting ; Lee, Mon Juan ; Chen, Chung Hwan ; Chuang, Shu Chun ; Chang, Li Fu ; Ho, Mei Ling ; Hung, Shao Hung ; Fu, Yin Chih ; Wang, Yan Hsiung ; Wang, Hsin I. ; Wang, Gwo Jaw ; Kang, Lin ; Chang, Je Ken. / Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. In: Journal of Cellular and Molecular Medicine. 2012 ; Vol. 16, No. 3. pp. 582-593.
@article{000a19f5e6654b6ea131e03948074370,
title = "Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures",
abstract = "Aging has less effect on adipose-derived mesenchymal stem cells (ADSCs) than on bone marrow-derived mesenchymal stem cells (BMSCs), but whether the fact holds true in stem cells from elderly patients with osteoporotic fractures is unknown. In this study, ADSCs and BMSCs of the same donor were harvested and divided into two age groups. Group A consisted of 14 young patients (36.4 ± 11.8 years old), and group B consisted of eight elderly patients (71.4 ± 3.6 years old) with osteoporotic fractures. We found that the doubling time of ADSCs from both age groups was maintained below 70 hrs, while that of BMSCs increased significantly with the number of passage. When ADSCs and BMSCs from the same patient were compared, there was a significant increase in the doubling time of BMSCs in each individual from passages 3 to 6. On osteogenic induction, the level of matrix mineralization of ADSCs from group B was comparable to that of ADSCs from group A, whereas BMSCs from group B produced least amount of mineral deposits and had a lower expression level of osteogenic genes. The p21 gene expression and senescence-associated β-galactosidase activity were lower in ADSCs compared to BMSCs, which may be partly responsible for the greater proliferation and differentiation potential of ADSCs. It is concluded that the proliferation and osteogenic differentiation of ADSCs were less affected by age and multiple passage than BMSCs, suggesting that ADSCs may become a potentially effective therapeutic option for cell-based therapy, especially in elderly patients with osteoporosis.",
author = "Chen, {Hui Ting} and Lee, {Mon Juan} and Chen, {Chung Hwan} and Chuang, {Shu Chun} and Chang, {Li Fu} and Ho, {Mei Ling} and Hung, {Shao Hung} and Fu, {Yin Chih} and Wang, {Yan Hsiung} and Wang, {Hsin I.} and Wang, {Gwo Jaw} and Lin Kang and Chang, {Je Ken}",
year = "2012",
month = "3",
day = "1",
doi = "10.1111/j.1582-4934.2011.01335.x",
language = "English",
volume = "16",
pages = "582--593",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "3",

}

Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. / Chen, Hui Ting; Lee, Mon Juan; Chen, Chung Hwan; Chuang, Shu Chun; Chang, Li Fu; Ho, Mei Ling; Hung, Shao Hung; Fu, Yin Chih; Wang, Yan Hsiung; Wang, Hsin I.; Wang, Gwo Jaw; Kang, Lin; Chang, Je Ken.

In: Journal of Cellular and Molecular Medicine, Vol. 16, No. 3, 01.03.2012, p. 582-593.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures

AU - Chen, Hui Ting

AU - Lee, Mon Juan

AU - Chen, Chung Hwan

AU - Chuang, Shu Chun

AU - Chang, Li Fu

AU - Ho, Mei Ling

AU - Hung, Shao Hung

AU - Fu, Yin Chih

AU - Wang, Yan Hsiung

AU - Wang, Hsin I.

AU - Wang, Gwo Jaw

AU - Kang, Lin

AU - Chang, Je Ken

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Aging has less effect on adipose-derived mesenchymal stem cells (ADSCs) than on bone marrow-derived mesenchymal stem cells (BMSCs), but whether the fact holds true in stem cells from elderly patients with osteoporotic fractures is unknown. In this study, ADSCs and BMSCs of the same donor were harvested and divided into two age groups. Group A consisted of 14 young patients (36.4 ± 11.8 years old), and group B consisted of eight elderly patients (71.4 ± 3.6 years old) with osteoporotic fractures. We found that the doubling time of ADSCs from both age groups was maintained below 70 hrs, while that of BMSCs increased significantly with the number of passage. When ADSCs and BMSCs from the same patient were compared, there was a significant increase in the doubling time of BMSCs in each individual from passages 3 to 6. On osteogenic induction, the level of matrix mineralization of ADSCs from group B was comparable to that of ADSCs from group A, whereas BMSCs from group B produced least amount of mineral deposits and had a lower expression level of osteogenic genes. The p21 gene expression and senescence-associated β-galactosidase activity were lower in ADSCs compared to BMSCs, which may be partly responsible for the greater proliferation and differentiation potential of ADSCs. It is concluded that the proliferation and osteogenic differentiation of ADSCs were less affected by age and multiple passage than BMSCs, suggesting that ADSCs may become a potentially effective therapeutic option for cell-based therapy, especially in elderly patients with osteoporosis.

AB - Aging has less effect on adipose-derived mesenchymal stem cells (ADSCs) than on bone marrow-derived mesenchymal stem cells (BMSCs), but whether the fact holds true in stem cells from elderly patients with osteoporotic fractures is unknown. In this study, ADSCs and BMSCs of the same donor were harvested and divided into two age groups. Group A consisted of 14 young patients (36.4 ± 11.8 years old), and group B consisted of eight elderly patients (71.4 ± 3.6 years old) with osteoporotic fractures. We found that the doubling time of ADSCs from both age groups was maintained below 70 hrs, while that of BMSCs increased significantly with the number of passage. When ADSCs and BMSCs from the same patient were compared, there was a significant increase in the doubling time of BMSCs in each individual from passages 3 to 6. On osteogenic induction, the level of matrix mineralization of ADSCs from group B was comparable to that of ADSCs from group A, whereas BMSCs from group B produced least amount of mineral deposits and had a lower expression level of osteogenic genes. The p21 gene expression and senescence-associated β-galactosidase activity were lower in ADSCs compared to BMSCs, which may be partly responsible for the greater proliferation and differentiation potential of ADSCs. It is concluded that the proliferation and osteogenic differentiation of ADSCs were less affected by age and multiple passage than BMSCs, suggesting that ADSCs may become a potentially effective therapeutic option for cell-based therapy, especially in elderly patients with osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=84863136375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863136375&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2011.01335.x

DO - 10.1111/j.1582-4934.2011.01335.x

M3 - Article

C2 - 21545685

AN - SCOPUS:84863136375

VL - 16

SP - 582

EP - 593

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 3

ER -